Table 4.
Ligands |
Inhibins, activins, myostatin, BMPs, GDFs, AMH, TGFβ1-3, nodal |
Extracellular antagonists |
Follistatin, follistatin-like 3, fibrillins, noggin, chordin, DAN/cereberus |
Type I receptors |
ACVR1, ACVR1B, ACVR1C, BMPR1A, BMPR1B, TGFβR1 |
Type II receptors |
ACVRL1, ACVR2A, ACVR2B, BMPR2, AMHR2, TGFβR2 |
Type III receptors |
TGFβR3, ENG, IgSF |
Intracellular modulators of signaling |
Smad1-8, Smurf1-2, SARA, TRAP1, BAMBI, Gsc |
ACVRs, Activin receptors; ACVRL1, activin A receptor type II-like 1; AMH, anti-Mullerian hormone; BAMBI, BMP and activin membrane-bound inhibitor homolog; BMPs, bone morphogenic proteins; DAN, differential screening-selected gene aberrative in neuroblastoma; ENG, endoglin; Gsc, goosecoid; GDFs, growth differentiation factors; IgSF, Ig superfamily; SARA, Smad anchor for receptor activation; Smads, Mothers against decapentaplegic homolog; R, receptor; TRAP-1, TGFβ receptor associated protein-1.